A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
11 2023
Historique:
revised: 23 09 2023
received: 25 07 2023
medline: 27 11 2023
pubmed: 17 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Despite advances in precision oncology, cancer remains a global public health issue. In this report, proof-of-principle evidence is presented that a cell-penetrable peptide (ACP52C) dissociates transcription factor CP2c complexes and induces apoptosis in most CP2c oncogene-addicted cancer cells through transcription activity-independent mechanisms. CP2cs dissociated from complexes directly interact with and degrade YY1, leading to apoptosis via the MDM2-p53 pathway. The liberated CP2cs also inhibit TDP2, causing intrinsic genome-wide DNA strand breaks and subsequent catastrophic DNA damage responses. These two mechanisms are independent of cancer driver mutations but are hindered by high MDM2 p60 expression. However, resistance to ACP52C mediated by MDM2 p60 can be sensitized by CASP2 inhibition. Additionally, derivatives of ACP52C conjugated with fatty acid alone or with a CASP2 inhibiting peptide show improved pharmacokinetics and reduced cancer burden, even in ACP52C-resistant cancers. This study enhances the understanding of ACP52C-induced cancer-specific apoptosis induction and supports the use of ACP52C in anticancer drug development.

Identifiants

pubmed: 37845006
doi: 10.1002/advs.202305096
pmc: PMC10667816
doi:

Substances chimiques

DNA-Binding Proteins 0
Transcription Factors 0
Peptides 0
TDP2 protein, human EC 3.1.4.-
Phosphoric Diester Hydrolases EC 3.1.4.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2305096

Subventions

Organisme : National Research Foundation of Korea, Bio & Medical Technology Development
ID : NRF-2017M3A9C8027975
Organisme : National Research Foundation of Korea, Basic Science Research Program
ID : 2010-0025223
Organisme : National Research Foundation of Korea, Basic Science Research Program
ID : 2014R1A2A1A11054432
Organisme : National Research Foundation of Korea, Basic Science Research Program
ID : NRF-2020R1A2C2009112

Informations de copyright

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Gene. 2004 Dec 8;343(1):23-40
pubmed: 15563829
Annu Rev Biochem. 1978;47:419-48
pubmed: 354501
Nature. 2019 Nov;575(7784):683-687
pubmed: 31748744
Anal Biochem. 2013 Oct 15;441(2):147-51
pubmed: 23871997
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Nucleic Acids Res. 2017 Jan 4;45(D1):D219-D227
pubmed: 27899601
Science. 2010 May 21;328(5981):1031-5
pubmed: 20378772
Protein Sci. 2020 Aug;29(8):1851-1857
pubmed: 32557917
Mol Cell Biol. 1988 Aug;8(8):3215-26
pubmed: 2905426
Mol Cell. 2011 Jul 8;43(1):57-71
pubmed: 21726810
J Mol Cell Biol. 2019 Jul 19;11(7):524-530
pubmed: 30925588
Nat Genet. 2022 Dec;54(12):1919-1932
pubmed: 36471071
Cell. 2017 Dec 14;171(7):1573-1588.e28
pubmed: 29224777
Nat Commun. 2015 Sep 15;6:8244
pubmed: 26372309
Cell Rep. 2017 Oct 31;21(5):1227-1239
pubmed: 29091762
J Pharmacol Sci. 2019 Dec;141(4):146-152
pubmed: 31744691
Mol Cell Biol. 2005 Jul;25(14):6005-20
pubmed: 15988015
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Exp Mol Med. 2021 Apr;53(4):517-527
pubmed: 33854186
Int J Mol Sci. 2018 Sep 20;19(10):
pubmed: 30241344
FEBS J. 2005 Mar;272(5):1265-77
pubmed: 15720400
Cold Spring Harb Symp Quant Biol. 1985;50:643-50
pubmed: 3938367
J Med Chem. 2019 Jan 24;62(2):445-447
pubmed: 30575392
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
Proteomics Clin Appl. 2014 Jun;8(5-6):427-37
pubmed: 24677670
Oncotarget. 2015 Sep 22;6(28):26266-77
pubmed: 26313006
Sci Adv. 2023 Jan 27;9(4):eadd4969
pubmed: 36706181
Nucleic Acids Res. 2010 Sep;38(16):5456-71
pubmed: 20421208
Dev Reprod. 2020 Dec;24(4):249-262
pubmed: 33537512
Nature. 2009 Oct 1;461(7264):674-8
pubmed: 19794497
Biochem Biophys Res Commun. 2009 Mar 20;380(4):813-7
pubmed: 19338758
Nat Clin Pract Oncol. 2006 Aug;3(8):448-57
pubmed: 16894390
Cancer Cell. 2021 Apr 12;39(4):466-479
pubmed: 33450197
Am J Cancer Res. 2012;2(3):269-85
pubmed: 22679558
Mech Dev. 2002 Jun;114(1-2):37-50
pubmed: 12175488
Mol Cell Biol. 1988 Oct;8(10):4270-81
pubmed: 3185549
Nature. 2000 Nov 23;408(6811):433-9
pubmed: 11100718
Oncotarget. 2017 Apr 11;8(15):24389-24400
pubmed: 28412749
Vet Clin North Am Small Anim Pract. 1994 Jan;24(1):89-102
pubmed: 8109077
Bioconjug Chem. 2009 Feb;20(2):213-21
pubmed: 19133717
Eur J Pharmacol. 2002 Sep 13;451(2):217-25
pubmed: 12231394
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70
pubmed: 15295102
Oncogene. 2003 Dec 4;22(55):8870-80
pubmed: 14654783
Cell. 1997 Oct 31;91(3):325-34
pubmed: 9363941
J Biomater Appl. 2016 Feb;30(7):995-1003
pubmed: 26491057
Cell Death Differ. 2018 Jan;25(1):114-132
pubmed: 29125603
Mol Cells. 2003 Feb 28;15(1):40-7
pubmed: 12661759
EMBO J. 1993 Feb;12(2):461-8
pubmed: 8440237
World J Gastroenterol. 2011 Aug 7;17(29):3420-30
pubmed: 21876634
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62
pubmed: 19805273
Nucleic Acids Res. 2018 Jun 1;46(10):4933-4949
pubmed: 29547954
Biochem Pharmacol. 2014 Feb 1;87(3):381-9
pubmed: 24291778
Trends Genet. 2020 Dec;36(12):981-997
pubmed: 32001024
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8357-62
pubmed: 20404171
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4503-8
pubmed: 22396589
ACS Med Chem Lett. 2018 Jun 15;9(7):577-580
pubmed: 30034579
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Cancer Res. 2020 Jun 1;80(11):2217-2229
pubmed: 32193292
Cancer Discov. 2023 May 4;13(5):1210-1229
pubmed: 36734633
Cell. 2009 May 15;137(4):609-22
pubmed: 19450511
Adv Sci (Weinh). 2023 Nov;10(33):e2305096
pubmed: 37845006
J Am Chem Soc. 2003 Feb 19;125(7):1731-7
pubmed: 12580598
Oncotarget. 2017 Jul 31;8(41):70538-70549
pubmed: 29050300

Auteurs

Seung Han Son (SH)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Min Young Kim (MY)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Sungwoo Choi (S)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Ji Sook Kim (JS)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.
Department of Pathology, Hanyang University College of Medicine, Seoul, 04763, South Korea.

Yong Sang Lee (YS)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Sangwon Lee (S)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Yeon Ju Lee (YJ)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Jin Youn Lee (JY)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Seol Eui Lee (SE)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Young Su Lim (YS)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Dae Hyun Ha (DH)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Eonju Oh (E)

Department of Bioengineering, College of Engineering, Hanyang University, Seoul, 04763, South Korea.

Young-Bin Won (YB)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Chang-Jun Ji (CJ)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Mi Ae Park (MA)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Boram Kim (B)

Department of Biotechnology and Research Institute for Biomedical and Health Science, College of Biomedical and Health Science, Konkuk University, Chungju, Chungbuk, 27478, South Korea.

Kyu Tae Byun (KT)

Department of Biotechnology and Research Institute for Biomedical and Health Science, College of Biomedical and Health Science, Konkuk University, Chungju, Chungbuk, 27478, South Korea.

Min Sung Chung (MS)

Department of Surgery, Hanyang University College of Medicine, Seoul, 04763, South Korea.

Jaemin Jeong (J)

Department of Surgery, Hanyang University College of Medicine, Seoul, 04763, South Korea.

Dongho Choi (D)

Department of Surgery, Hanyang University College of Medicine, Seoul, 04763, South Korea.

Eun Jung Baek (EJ)

Department of Laboratory Medicine, Hanyang University College of Medicine, Seoul, 04763, South Korea.

Eung-Ho Cho (EH)

Department of Surgery, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, South Korea.

Sang-Bum Kim (SB)

Department of Surgery, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, South Korea.

A Reum Je (AR)

Center for Research Equipment, Korea Basic Science Institute, Cheongju, 28119, South Korea.

Hee-Seok Kweon (HS)

Center for Research Equipment, Korea Basic Science Institute, Cheongju, 28119, South Korea.

Hyun Sook Park (HS)

CEFO Co. Ltd., Seoul, 03150, South Korea.

Dongsun Park (D)

Department of Biology Education, Korea National University of Education, Cheongju, Chungbuk, 29173, South Korea.

June Sung Bae (JS)

Department of Research and Development, OncoClew Co. Ltd, Seoul, 04778, South Korea.

Se Jin Jang (SJ)

Department of Research and Development, OncoClew Co. Ltd, Seoul, 04778, South Korea.
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Asan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, Seoul, 05505, South Korea.

Chae-Ok Yun (CO)

Department of Bioengineering, College of Engineering, Hanyang University, Seoul, 04763, South Korea.

Ji Hyung Chae (JH)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Jin-Won Lee (JW)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Su-Jae Lee (SJ)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Chan Gil Kim (CG)

Department of Biotechnology and Research Institute for Biomedical and Health Science, College of Biomedical and Health Science, Konkuk University, Chungju, Chungbuk, 27478, South Korea.

Ho Chul Kang (HC)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.

Vladimir N Uversky (VN)

Department of Molecular Medicine and USF Health Byrd Alzheimer`s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.

Chul Geun Kim (CG)

Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul, 04763, South Korea.
CGK Biopharma Co. Ltd., Seoul, 04763, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH